Toth Financial Advisory Corp Amgen Inc Transaction History

Toth Financial Advisory Corp

$817 Million
Q4 2024

A detailed history of Toth Financial Advisory Corp transactions in Amgen Inc stock. As of the latest transaction made, Toth Financial Advisory Corp holds 25,562 shares of AMGN stock, worth $7.5 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

25,562

Previous 26,119 2.13%

Holding current value

$7.5 Million

Previous $8.42 Million 20.83%

% of portfolio

0.82%

Previous 1.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$258.78 - $328.31 $144,140 - $182,868	-557 Reduced 2.13%	25,562 $6.66 Million
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $285,557 - $311,401	-923 Reduced 3.41%	26,119 $8.42 Million
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $189,705 - $230,541	-722 Reduced 2.6%	27,042 $8.45 Million
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $86,576 - $104,508	-322 Reduced 1.15%	27,764 $7.89 Million
Q4 2023 Jan 26, 2024	BUY	$255.7 - $288.46 $151,374 - $170,768	592 Added 2.15%	28,086 $8.09 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $52,257 - $64,878	-239 Reduced 0.86%	27,494 $7.39 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $156,202 - $184,706	-729 Reduced 2.56%	27,733 $6.16 Million
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $68,640 - $83,660	-304 Reduced 1.06%	28,462 $6.88 Million
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $187,346 - $238,046	818 Added 2.93%	28,766 $0
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $214,134 - $241,505	954 Added 3.53%	27,948 $6.3 Million
Q2 2022 Jul 25, 2022	BUY	$230.71 - $256.74 $707,587 - $787,421	3,067 Added 12.82%	26,994 $6.57 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $385,915 - $426,923	1,760 Added 7.94%	23,927 $5.79 Million
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $916,240 - $1.05 Million	-4,607 Reduced 17.21%	22,167 $4.99 Million
Q3 2021 Oct 20, 2021	SELL	$212.27 - $248.7 $211,633 - $247,953	-997 Reduced 3.59%	26,774 $5.69 Million
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $104,176 - $115,576	446 Added 1.63%	27,771 $6.77 Million
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $76,337 - $88,958	344 Added 1.27%	27,325 $6.8 Million
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $71,189 - $84,773	-329 Reduced 1.2%	26,981 $6.2 Million
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $321,235 - $357,240	1,369 Added 5.28%	27,310 $6.94 Million
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $787,283 - $966,105	3,980 Added 18.12%	25,941 $6.12 Million
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $82,919 - $109,973	455 Added 2.12%	21,961 $4.45 Million
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $913,505 - $1.17 Million	4,828 Added 28.95%	21,506 $5.18 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $551,580 - $660,908	3,168 Added 23.45%	16,678 $3.23 Million
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $87,684 - $102,785	526 Added 4.05%	13,510 $2.49 Million
Q1 2019 Apr 15, 2019	SELL	$180.87 - $203.88 $23,874 - $26,912	-132 Reduced 1.01%	12,984 $2.47 Million
Q4 2018 Jan 22, 2019	SELL	$178.4 - $208.25 $94,908 - $110,789	-532 Reduced 3.9%	13,116 $2.55 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $25,199 - $28,409	-136 Reduced 0.99%	13,648 $2.83 Million
Q2 2018 Jul 23, 2018	BUY	$166.05 - $186.51 $34,372 - $38,607	207 Added 1.52%	13,784 $2.54 Million
Q1 2018 Apr 25, 2018	SELL	$169.43 - $198.0 $49,642 - $58,014	-293 Reduced 2.11%	13,577 $2.32 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $45,066 - $50,353	267 Added 1.96%	13,870 $2.41 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $2.28 Million - $2.6 Million	13,603	13,603 $2.54 Million

Others Institutions Holding AMGN

# of Institutions

3,095

Shares Held

405M

Call Options Held

7.57M

Put Options Held

7.12M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.

Account

Toth Financial Advisory Corp Amgen Inc Transaction History